David Erlinge
411 – 420 of 505
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Can We Do More for the STEMI Patient than Restore Coronary Blood Flow?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Agreement of left ventricular mass in steady state free precession and delayed enhancement MR images : Implications for quantification of fibrosis in congenital and ischemic heart disease
(
- Contribution to journal › Article
- 2009
-
Mark
Mild Hypothermia Increases Adenosine Diphosphate-Stimulated Platelet Aggregation After Clopidogrel Administration in Healthy Volunteers
2009) 10th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology In Arteriosclerosis, Thrombosis and Vascular Biology 29(7). p.86-86(
- Contribution to journal › Published meeting abstract
-
Mark
Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease
(
- Contribution to journal › Article
-
Mark
Assessment of P2Y(12) inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirin
(
- Contribution to journal › Article
-
Mark
Mild hypothermia does not attenuate platelet aggregation and may even increase ADP-stimulated platelet aggregation after clopidogrel treatment
(
- Contribution to journal › Article
- 2008
-
Mark
ADP mediates inhibition of insulin secretion by activation of P2Y(13) receptors
2008) 44th EASD Annual Meeting of the European Association for the Study of Diabetes In Diabetologia 51(S1). p.197-197(
- Contribution to journal › Published meeting abstract
-
Mark
ADP mediates inhibition of insulin secretion by activation of P2Y13 receptors
(
- Contribution to journal › Published meeting abstract
-
Mark
Pharmacological characterization of the P2Y11 Thr-87 variant
(
- Contribution to journal › Published meeting abstract
-
Mark
P2-polymorphisms and cardiovascular disease
(
- Contribution to journal › Published meeting abstract